Our Therapeutic Focus

Our robust therapeutic portfolio is the result of keen insights into multiple disease states for which we’re developing potential treatments, including plasma and non-plasma solutions alike. Understanding the mechanisms of action through which our therapies impact human health has already enabled Grifols to help enhance the daily lives of millions of patients and their families. 

Well-rounded portfolio

Our pipeline of approximately 40 priority research projects in various development stages highlights a diverse and targeted therapeutic approach.